Regulation - Reproductive, Markets & Marketing


Popular Filters

Bayer expects EU launch of new long-term contraceptive system Jaydess in 2nd-qtr 2013


German drug major Bayer (BAYN: DE) has successfully concluded the European Union registration procedure…

BayerEuropeJaydessLevonorgestrelMarkets & MarketingPharmaceuticalRegulationReproductive

Warner Chilcott sues Watson over Lo Loestrin; Actavis debuts generic Requip


Ireland-headquartered Warner Chilcott (Nasdaq: WCRX) has filed suit against USA-based Watson Pharmaceuticals…

ActavisGenericsGlaxoSmithKlineLegalLo LoestrinMarkets & MarketingNeurologicalNorth AmericaPatentsRegulationReproductiveRequip XLWarner ChilcottWatson Pharmaceuticals

Back to top